Taking people in FranceNo phase
Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty
Key facts
- Who runs it
- Corin
- Where
- Amboise, Hénin-Beaumont, and Paris, FranceSee the 4 sites
- Trial code
- Status
- Recruiting
- People taking part
- 368 people, planned
- Started
- 29 Jun 2023
- Expected to end
- Sept 2035
- Type of study
- Observational
- Treatments tested
- Bipolar i and cemented stem (Océane+ or Meije)
- Record updated
- 18 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Both genders
- Adult subjects
- Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices based on physical examination, medical history and diagnosis such as: non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, revision of failed partial hip replacements in which the acetabulum does not require replacement
- The subject is willing to comply with the required follow-up visits as per protocol
- The subject, or a designated trusted person in case the subject is unable to do, has signed a Patient Informed Consent Form (PICF), specific to this study, and approved by the local EC
Who cannot take part
- Subjects with active infection or sepsis or osteomyelitis
- Subject with metabolic disorders which may impair bone formation or bone quality
- Subjects in the opinion of the Investigator/ investigative team who will be unable to comply with study procedures (Examples: recent psychotic or mania disorders, alcohol, drug or substance abusers) and/or those unable for any medical or other reason to comply with study procedures/visits
- Subjects with unsuitable or insufficient bone support preventing proper fixation of the prosthesis
- Subject with marked bone loss or bone absorption
- Subjects under guardianship
- Subjects under jusicial protection
Where in France
- Ch AmboiseAmboise, FranceContact: Vincent NOEL, MDTaking people
- Polyclinique Henin BeaumontHénin-Beaumont, FranceContact: Vanessa GRIMAUDNo longer taking part
- Hopital Diaconesses-Croix Saint SimonParis, FranceContact: Guillaume AUBERGER, MDNot yet recruiting
- Hopital Saint JosephParis, FranceContact: Peter UPEX, MDTaking people
About the trial
What the trial wants to find out
This PMCF study is designed to collect safety and efficacy data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.
The group in the trial
- Hip hemiarthroplasty with BiPolar i and cemented stems (Meije or Oceane+)
Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices
Treatment: Bipolar i and cemented stem (Océane+ or Meije)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Post-market Clinical Follow-up (PMCF) Study to Evaluate Clinical, Radiographic and Patient Reported Outcomes Following a Hip Hemiarthroplasty Surgery Using Corin Devices
- Record updated
- 18 March 2026